European Society for Medical Oncology Preceptorship on Immuno-Oncology 2022

Description

+ Include: 26 videos + 29 pdfs, size: 2.1 GB

+ Target Audience: oncologist, immunologist

+ Sample video: contact me for sample video

+ Topics:

ESMO-Preceptorship-on-Immuno-Oncology-2022-Singapore-Programme.pdf
Session 1 Principles of tumour immunology Explaining cellular immunity and immune surveillance.mp4
Session 1 Principles of tumour immunology Explaining cellular immunity and immune surveillance.pdf
Session 2 Balancing costs and clinical benefit in medical oncology.mp4
Session 2 Balancing costs and clinical benefit in medical oncology.pdf
Session 2 Clinical translation and radiological assessment of efficacy.mp4
Session 2 Clinical translation and radiological assessment of efficacy.pdf
Session 2 Immune related toxicities and management.mp4
Session 2 Immune related toxicities and management.pdf
Session 2 Predictive biomarkers and response.pdf
Session 3 Hepatocellular carcinoma (HCC).mp4
Session 3 Hepatocellular carcinoma (HCC).pdf
Session 3 Non-small cell lung cancer (NSCLC).mp4
Session 3 Non-small cell lung cancer (NSCLC).pdf
Session 3 Participant clinical case discussion.mp4
Session 3 Participant clinical case discussion.pdf
Session 3 Upper GI and colorectal.mp4
Session 3 Upper GI and colorectal.pdf
Session 4 Participant clinical case discussion 1.mp4
Session 4 Participant clinical case discussion 1.pdf
Session 4 Participant clinical case discussion 2.mp4
Session 4 Participant clinical case discussion 2.pdf
Session 4 Participant clinical case discussion 3.mp4
Session 4 Participant clinical case discussion 3.pdf
Session 5 Advanced urinary cancer (renal and bladder).mp4
Session 5 Advanced urinary cancer (renal and bladder).pdf
Session 5 Gynaecological malignancies and breast cancer.mp4
Session 5 Gynaecological malignancies and breast cancer.pdf
Session 5 Head and neck cancer.mp4
Session 5 Head and neck cancer.pdf
Session 5 Melanoma advanced and adjuvant.mp4
Session 5 Melanoma advanced and adjuvant.pdf
Session 6 Participant clinical case discussion 1.mp4
Session 6 Participant clinical case discussion 1.pdf
Session 6 Participant clinical case discussion 2.mp4
Session 6 Participant clinical case discussion 2.pdf
Session 6 Participant clinical case discussion 3.mp4
Session 6 Participant clinical case discussion 3.pdf
Session 6 Participant clinical case discussion 4.mp4
Session 6 Participant clinical case discussion 4.pdf
Session 6 Participant clinical case discussion 5.mp4
Session 6 Participant clinical case discussion 5.pdf
Session 6 Participant clinical case discussion 6.mp4
Session 6 Participant clinical case discussion 6.pdf
Session 6 Participant clinical case discussion 7.mp4
Session 6 Participant clinical case discussion 7.pdf
Session 7 Cellular therapy for haematological malignancies.mp4
Session 7 Cellular therapy for haematological malignancies.pdf
Session 7 Cellular therapy for solid tumours.mp4
Session 7 Cellular therapy for solid tumours.pdf
Session 7 Combination therapy Future directions.mp4
Session 7 Combination therapy Future directions.pdf
Session 7 Immunotherapy and the microbiome Current use and future directions.mp4
Session 7 Immunotherapy and the microbiome Current use and future directions.pdf
Welcome.pdf